Real-world Data from KRAS-mutant Advanced NSCLC: the ATLAS Multicenter Cohort Study

被引：0
|
作者：
Bungaro, M. [1 ]
Garbo, E. [1 ]
Jacobs, F. [1 ]
Reale, M. L. [1 ]
Passiglia, F. [1 ]
Tiseo, M. [2 ]
Genova, C. [3 ]
Galetta, D. [4 ]
Malapelle, U. [5 ]
Troncone, G.
Novello, S. [1 ,5 ]
机构：
[1] Univ Turin, San Luigi Gonzaga Hosp, Turin, Italy
[2] Univ Parma, Med Oncol Unit, Parma, Italy
[3] IRCCS Osped San Martino, Genoa, Italy
[4] IRCCS Ist Tumori Giovanni Paolo II, Bari, Italy
[5] Univ Naples Federico II, Naples, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
Real-world data; NSCLC; KRAS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-10
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [1] Efficacy of immunotherapy in KRAS-mutant advanced NSCLC: A real-world study in a Chinese population
    Peng, Lixiu
    Guo, Jun
    Kong, Li
    Huang, Yong
    Tang, Ning
    Zhang, Juguang
    Wang, Minglei
    He, Xiaohan
    Li, Zhenzhen
    Peng, Yonggang
    Wang, Zhehai
    Han, Xiao
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [2] Distant Metastasis Pattern and Baseline Clinicopathological Features from a Real-World KRAS G12C Mutant Cohort of Advanced NSCLC Patients
    Mollica, L.
    Intagliata, S.
    Bonomi, L.
    Ghilardi, L.
    Morotti, D.
    Ghirardi, G.
    Antelmi, E.
    Gianatti, A.
    Carioli, G.
    Muglia, R.
    Marra, P.
    Raimondi, F.
    Ciaravino, G.
    Di Marco, F.
    Sironi, S.
    Tondini, C. A.
    Bettini, A. C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S495 - S496
  • [3] Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study
    Gwo-Fuang Ho
    Chee-Shee Chai
    Adlinda Alip
    Mohd Ibrahim A. Wahid
    Matin Mellor Abdullah
    Yoke-Ching Foo
    Soon-Hin How
    Adel Zaatar
    Kai-Seng Lam
    Kin-Wah Leong
    John-Seng-Hooi Low
    Mastura Md Yusof
    Erica Chai-Yong Lee
    Yok-Yong Toh
    Chong-Kin Liam
    BMC Cancer, 19
  • [4] Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study
    Ho, Gwo-Fuang
    Chai, Chee-Shee
    Alip, Adlinda
    Wahid, Mohd Ibrahim A.
    Abdullah, Matin Mellor
    Foo, Yoke-Ching
    How, Soon-Hin
    Zaatar, Adel
    Lam, Kai-Seng
    Leong, Kin-Wah
    Low, John-Seng-Hooi
    Yusof, Mastura Md
    Lee, Erica Chai-Yong
    Toh, Yok-Yong
    Liam, Chong-Kin
    BMC CANCER, 2019, 19 (01)
  • [5] Cenobamate: real-world data from a retrospective multicenter study
    Lauxmann, Stephan
    Heuer, David
    Heckelmann, Jan
    Fischer, Florian P.
    Schreiber, Melanie
    Schriewer, Elisabeth
    Widman, Guido
    Weber, Yvonne
    Lerche, Holger
    Alber, Michael
    Schuh-Hofer, Sigrid
    Wolking, Stefan
    JOURNAL OF NEUROLOGY, 2024, : 6596 - 6604
  • [6] REAL-IMPACT: Real-World Effectiveness of Immunotherapy in PD-L1 Negative Advanced NSCLC A Multicenter Cohort Study in Argentina
    Picon, C. R.
    Rizzo, M. M.
    Sanchez del Cid, M.
    Amorin, R.
    Tsou, F.
    Castro, N.
    Garcia, M. B.
    Cheng, S.
    Scocimarro, A.
    Rapaccioli, M.
    Castagneris, N.
    Malcervelli, G.
    Levit, P.
    Carranza, O.
    Piazzoni, L.
    Kaen, D.
    Ayala, N.
    Martin, C.
    Lupinacci, L.
    Puparelli, C.
    Basbus, L.
    Enrico, D.
    Garcia Giner, B.
    Perfetti, A.
    Vera, K.
    Bluthgen, V.
    Sena, S.
    Riso, A.
    Gayet Preiss, F.
    Kowalyszyn, R.
    Barbaro, F.
    Santa Cruz, M. A.
    Bastida, N.
    Minatta, J. N.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S605 - S606
  • [7] Cabozantinib in advanced hepatocellular carcinoma: Efficacy and safety data from an international multicenter real-world cohort.
    Finkelmeier, Fabian
    Scheiner, Bernhard
    Leyh, Catherine
    Best, Jan
    Frundt, Thorben Wilhelm
    Czauderna, Carolin
    Beutel, Alica
    Bettinger, Dominik
    Weiss, Johannes
    Meischl, Tobias
    Kuetting, Fabian
    Waldschmidt, Dirk Thomas
    Schultheiss, Michael
    Ettrich, Thomas Jens
    Weinmann, Arndt
    Wege, Henning
    Venerito, Marino
    Lange, Christian
    Pinter, Matthias
    Waidmann, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC
    Maione, Paolo
    Sgambato, Assunta
    Rossi, Antonio
    Sacco, Paola Claudia
    Bareschino, Maria Anna
    Schettino, Clorinda
    Casaluce, Francesca
    Ciardiello, Fortunato
    Gridelli, Cesare
    REVIEWS ON RECENT CLINICAL TRIALS, 2013, 8 (02) : 93 - 100
  • [9] Real-World Evidence Study of Patients with KRAS-Mutated NSCLC in Finland
    Anttalainen, Anna
    Pietarinen, Paavo
    Tuominen, Samuli
    Mattila, Riikka
    Mutka, Aino
    Knuuttila, Aija
    CURRENT ONCOLOGY, 2024, 31 (05) : 2700 - 2712
  • [10] ALK Testing in Chinese Advanced NSCLC Patients: A National-Wide Multicenter Prospective Real-World Data Study (The RATICAL Study)
    Ying, J.
    Li, L.
    Li, W.
    Li, Y.
    Xia, Q.
    Teng, X.
    Liu, Y.
    Chen, G.
    Qiu, X.
    Wu, W.
    Ji, Y.
    Wang, Z.
    Yan, X.
    Han, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S497 - S497
12345